CLSI NBS07:2017(R2022)
Current
Current
The latest, up-to-date edition.
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid α-Glucosidase Activity Assays
Available format(s)
Hardcopy , PDF
Language(s)
English
Published date
01-06-2022
Publisher
$504.59
Including GST where applicable
This report discusses the detection of Pompe disease (PD), also known as glycogen storage disease type II, by population-based newborn dried blood spot (DBS) screening, and focuses on enzyme activity assays for detecting PD.
| DocumentType |
Standard
|
| ISBN |
1-56238-814-2
|
| Pages |
70
|
| PublisherName |
Clinical Laboratory Standards Institute
|
| Status |
Current
|
| Supersedes |
Summarise
Access your standards online with a subscription
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.
Important note : All end users must be registered with an Account prior to user licenses being assigned.